We Ran for Fun Through Hyde Park!

Posted:
7
June 2004

7th June 2004We Ran for Fun Through Hyde Park!

[Runners in Hyde park]

Four Richmond Pharmacology managers braved the recent 10k Capital FM Bupa Featbeat fun run through Hyde Park! Sarah Willison, Victoria Blades, Chris Robinson and Sian Dale took part in the fund raising event, held on 23 May 2004.Our runners joined 7,000 other fun runners to raise money for Help a London Child. The run started at the Prince of Wales Gate in Hyde Park, taking runners along New Ride and up to Hyde Park Corner. Runners then ran past Grosvenor Gate and around the The Ring to The Serpentine lake. At which point, runners had to turnaround and run all the way back again!Victoria, Head of Clinical Project Management, commented “I felt fine until we reached The Serpentine but then my heart sank when I realized we had to run all the way back again! I think I need to take the training a bit more seriously before the next fun run!”Sarah Willison, Senior Project Manager, added “The last two miles didn’t feel fun! It was a great atmosphere though – the crowd were fantastic.”Richmond Pharmacology sponsored the four runners, donating £600 to the charity. They have already agreed to run the Windsor Half Marathon on 26 September 2004.Victoria commented: “Running over twice as far as we did in Hyde Park will certainly be a challenge! But its good to contribute in some small way to Help a London Child, so I had better get some training mileage done in the meantime!”For more information on events to raise funds for Help a London Child please visit www.capitalfm.com

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020
Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.
Read more

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more